Myovant Return on Average Equity Trend from 2010 to 2021

Myovant Sciences Return on Average Equity yearly trend continues to be fairly stable with very little volatility. Return on Average Equity is likely to outpace its year average in 2021. During the period from 2010 to 2021, Myovant Sciences Return on Average Equity regression line of quarterly data had r-squared of 0.11 and coefficient of variation of  1,167. Myovant Sciences Research and Development Expense is fairly stable at the moment as compared to the past year. Myovant Sciences reported Research and Development Expense of 136.71 Million in 2020. Selling General and Administrative Expense is likely to climb to about 195.7 M in 2021, whereas Earning Before Interest and Taxes EBIT is likely to drop (263.7 M) in 2021.

Search Historical Trends 

 
Refresh
Check Myovant Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Myovant main balance sheet or income statement drivers, such as Cost of Revenue of 269.3 K, Gross Profit of 52.8 M or Interest Expense of 10.4 M, as well as many exotic indicators such as Asset Turnover of 0.12, Current Ratio of 2.92 or Free Cash Flow per Share of 4.42. Myovant financial statements analysis is a perfect complement when working with Myovant Sciences Valuation or Volatility modules. It can also supplement various Myovant Sciences Technical models. Additionally, see Stocks Correlation.

Myovant Return on Average Equity Breakdown

Showing smoothed Return on Average Equity of Myovant Sciences with missing and latest data points interpolated. Return on equity measures a corporation's profitability by calculating the amount of Net Income Common Stock returned as a percentage of [EquityAvg].Myovant Sciences' Return on Average Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Myovant Sciences' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 20.67 %10 Years Trend
Increasing
Slightly volatile
 Return on Average Equity 
Share
      Timeline 

Myovant Return on Average Equity Regression Statistics

Arithmetic Mean 0.52
Coefficient Of Variation 1,167
Mean Deviation 3.29
Median(1.09)
Standard Deviation 6.12
Sample Variance 37.40
Range 25.06
R-Value 0.33
Mean Square Error 36.67
R-Squared 0.11
Significance 0.30
Slope 0.56
Total Sum of Squares 411.38

Myovant Return on Average Equity History

2017 (1.49) 
2018 (5.90) 
2019  19.16 
2020  1.06 
2021  1.09 

About Myovant Sciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Myovant Sciences income statement, its balance sheet, and the statement of cash flows. Myovant Sciences investors use historical funamental indicators, such as Myovant Sciences's Return on Average Equity, to determine how well the company is positioned to perform in the future. Although Myovant Sciences investors may use each financial statement separately, they are all related. The changes in Myovant Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Myovant Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Myovant Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Myovant Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Return on Average Equity 1.06  1.09 
Average Assets440.4 M349.5 M
Average Equity-239.8 M-246.1 M
Invested Capital Average177 M191 M
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for womens health and endocrine diseases. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 407 people.

Myovant Sciences Investors Sentiment

The influence of Myovant Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Myovant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - MYOV

Myovant Sciences Investor Sentiment

Most of Macroaxis users are now bullish on Myovant Sciences. What is your trading attitude regarding investing in Myovant Sciences? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Myovant Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Tools for Myovant Stock

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go